Efficacy and safety findings from MANTRA: A global, randomized, multicenter, phase III study of the MDM2 inhibitor milademetan vs trabectedin in patients with dedifferentiated liposarcomas
Refereed conference paper presented and published in conference proceedings
Full Text
Digital Object Identifier (DOI) DOI for CUHK Users View Full-text in Publisher Website |
Altmetrics Information
.
Other information
All Author(s) ListChen T.W-W., Sanfilippo R., Jones R.L., Schuetze S.M., Sebio Garcia A., Alvarez R.M., Bui N., Ahn J-H., Loong H.H.F., Yen C-C., Hong J.Y., Kim H.S., Patel S., Bryce R.P., Xu F., Zhang B., Shah N.V., Doebele R.C., Schwartz G., Gounder M.
Name of ConferenceAnnual Meeting of the European-Society-for-Medical-Oncology (ESMO)
Start Date of Conference01/12/2023
End Date of Conference03/12/2023
Place of ConferenceSingapore
Country/Region of ConferenceSingapore
Proceedings TitleAnnals of Oncology
Detailed descriptionAnnual Meeting of the European-Society-for-Medical-Oncology (ESMO)
Year2023
Month11
Volume Number34
Issue NumberSuppl. 4
PublisherELSEVIER
PagesS1496 - S1496
ISSN0923-7534
LanguagesEnglish-United States
